Utility of Neutrophil-To-Lymphocyte Ratio as Prognostic Marker of Dilated Cardiomyopathy in Children
DOI:
https://doi.org/10.36283/ziun-pjmd14-2/017Keywords:
Biomarker , Dilated Cardiomyopathy , Heart Failure , Neutrophil , LymphocyteAbstract
Background: Dilated cardiomyopathy (DCM) is a frequent form of cardiomyopathy exhibiting systolic and/or diastolic dysfunction, leading to varying degrees of heart failure (HF). The present research was aimed at assessing the utility of neutrophil-to-lymphocyte ratio (NLR) as a prognostic marker of DCM in children.
Methods: This cohort study was conducted at the Department of Pediatrics, Rai Teaching Hospital, Sargodha, Pakistan, from October 2022 to September 2024. Seventy-four children of both genders aged up to 18 years with an established diagnosis of DCM and taking treatment for chronic HF were analyzed. Non-probability, consecutive sampling technique was adopted. The NLR for each patient was determined by dividing the total count of neutrophils by the total count of lymphocytes. Children were advised a bi-monthly follow-up and outcomes were recorded after 6 months. The chi-square test was applied to compare categorical data whereas an independent sample t-test was employed for comparing numeric data. P<0.05 was labeled as the level of significance.
Results: In a total of 74 patients, 43 (58.1%) were boys. The mean age was 4.61±4.37 years. By the end of the mandatory period of 6-month follow-up, mortality was reported among 18 (24.3%) children. The need for readmission was significantly higher among children who died (72.2% vs. 26.8%, p=0.030). The mean NRL among children who survived was significantly lower than those who died (1.7±1.9 vs. 4.9±3.8, p<0.001). Among patients who died, oxygen saturation (p=0.046), and LVEF were significantly lower at the time of enrollment when compared to those who survived (p=0.002).
Conclusion: The study demonstrated that NLR may hold promise as a prognostic marker for pediatric DCM. The significant association between lower NLR and survival highlights the potential utility of this simple and cost-effective biomarker in risk stratification and clinical decision-making.
References
Agrawal A, Janjua D, Alsayed AZAA, Taher EA. Heart failure in children and adolescents: an update on diagnostic approaches and management. Clin Exp Pediatr. 2024;67(4):178-190. doi: 10.3345/cep.2023.00528
Mallavarapu A, Taksande A. Dilated Cardiomyopathy in Children: Early Detection and Treatment. Cureus. 2022;14(11):e31111. doi:10.7759/cureus.31111
Mumbulu ET, Nkodila AN, Saint-Joy V, Moussinga N, Makulo JR, Buila NB. Survival and predictors of mortality in patients with heart failure in the cardiology department of the Center Hospitalier Basse Terre in Guadeloupe: historical cohort study. BMC Cardiovasc Disord. 2024;24(1):599. doi: 10.1186/s12872-024-04268-1
Jenča D, Melenovský V, Stehlik J, Stanek V, Kettner J, Kautzner J, et al. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 2021;8(1):222-237. doi:10.1002/ehf2.13144
Chen S, Chen L, Duru F, Hu S. Heart Failure in Patients with Arrhythmogenic Cardiomyopathy. J Clin Med. 2021;10(20):4782. doi:10.3390/jcm10204782
Alfaddagh A, Martin SS, Leucker TM, Michos ED, Blaha MJ, Lowenstein CJ, et al. Inflammation and cardiovascular disease: From mechanisms to therapeutics. Am J Prev Cardiol. 2020;4:100130. doi:10.1016/j.ajpc.2020.100130
Karaca G, Ekmekci A, Kimiaei A, Safaei S, Özer N, Tayyareci G. The Impact of the Neutrophil-to-Lymphocyte Ratio on In-Hospital Outcomes in Patients With Acute ST-Segment Elevation Myocardial Infarction. Cureus. 2024;16(2):e54418. doi: 10.7759/cureus.54418
Bagyura Z, Kiss L, Lux Á, Csaba C, Jermendy AL, Polgar L, et al. Neutrophil-to-Lymphocyte Ratio Is an Independent Risk Factor for Coronary Artery Disease in Central Obesity. Int J Mol Sci. 2023;24(8):7397. doi:10.3390/ijms24087397
Wang W, Liu L, Ning Z, Che L, Li X. The neutrophil-lymphocyte ratio to predict poor prognosis of critical acute myocardial infarction patients: a retrospective cohort study. Biochem Med (Zagreb). 2023;33(1):010702. doi:10.11613/BM.2023.010702
Kantor FP, Rusconi P. Biomarkers in pediatric heart failure: their role in diagnosis and evaluating disease progression. Prog Pediatr Cardiol. 2011;33:53‑7. doi: 10.1016/j.ppedcard.2011.06.003
Tsirka AE, Trinkaus K, Chen SC, Lipshultz SE, Towbin JA, Colan SD, et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 2004 Jul 21;44(2):391-7. doi: 10.1016/j.jacc.2004.04.035
Zhang JL, Yang R, Zhu Y, Shao Y, Ji Y, Wang FF. Association between the neutrophil-to-lymphocyte ratio and risk of in-hospital heart failure and arrhythmia in patients with acute myocardial infarction. Front Cardiovasc Med. 2023 Oct 20;10:1275713. doi: 10.3389/fcvm.2023.1275713
Qi B, Yang ZJ, Huang N, Zheng WB, Gui C. Exploring the diagnostic and prognostic value of the C-reactive protein/lymphocyte ratio for dilated cardiomyopathy based on a real-world study. Sci Rep. 2023;13(1):18889. doi: 10.1038/s41598-023-46338-y
Vakhshoori M, Nemati S, Sabouhi S, Yavari B, Shakarami M, Bondariyan N, et al. Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023;23(1):555. doi: 10.1186/s12872-023-03572-6
Lillo R, Graziani F, Franceschi F, Iannaccone G, Massetti M, Olivotto I, et al. Inflammation across the spectrum of hypertrophic cardiac phenotypes. Heart Fail Rev. 2023;28(5):1065-1075. doi: 10.1007/s10741-023-10307-4
Araújo FDDR, Silva RMFDL, Oliveira CAL, Meira ZMA. Neutrophil-to-lymphocyte ratio used as prognostic factor marker for dilated cardiomyopathy in childhood and adolescence. Ann Pediatr Cardiol. 2019;12(1):18-24. doi:10.4103/apc.APC_47_18
Ozyilmaz S, Akgul O, Uyarel H, Pusuroglu H, Gul M, Satilmisoglu MH, et al. The importance of the neutrophil-to-lymphocyte ratio in patients with hypertrophic cardiomyopathy. Rev Port Cardiol. 2017;36(4):239-246. doi:10.1016/j.repc.2016.09.014
Durmus E, Kivrak T, Gerin F, Sunbul M, Sari I, Erdogan O. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure. Arq Bras Cardiol. 2015;105(6):606-613. doi:10.5935/abc.20150126
Cho JH, Cho HJ, Lee HY, Ki Y, Jeon E, Hwang K, et al. Neutrophil-Lymphocyte Ratio in Patients with Acute Heart Failure Predicts In-Hospital and Long-Term Mortality. J Clin Med. 2020;9(2):557. Published 2020 Feb 18. doi:10.3390/jcm9020557
Huang X, Qin Z, Xu M, Zhang F, Jiang X, Hua F, et al. Neutrophil: lymphocyte ratio is positively associated with subclinical diabetic cardiomyopathy. BMC Endocr Disord. 2020;20(1):99. doi:10.1186/s12902-020-00571-y
Delcea C, Buzea CA, Dan GA. The neutrophil to lymphocyte ratio in heart failure: a comprehensive review. Rom J Intern Med. 2019;57(4):296-314. doi:10.2478/rjim-2019-0018
Avci A, Alizade E, Fidan S, Yesin M, Guler Y, Kargin R, et al. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy. Scand Cardiovasc J. 2014;48(4):202-8. doi: 10.3109/14017431.2014.932922
Wang Y, Zhuang Y, Lin C, Hong H, Chen F, Ke J. The neutrophil-to-lymphocyte ratio is associated with coronary heart disease risk in adults: A population-based study. PLoS One. 2024;19(2):e0296838. doi: 10.1371/journal.pone.0296838
Ahmed M, El Amrousy D, Hodeib H, Elnemr S. Neutrophil-to-lymphocyte ratio as a predictive and prognostic marker in children with dilated cardiomyopathy. Cardiol Young. 2023;33(12):2493-2497. doi: 10.1017/S1047951123000501
Gao P, Liu J, Wang X, Zhang P, Jin Y, Bai L, et al. The association between neutrophil-lymphocyte ratio and poor outcomes following infant cardiac surgery. BMC Cardiovasc Disord. 2021;21(1):529. doi: 10.1186/s12872-021-02345-3. Retraction in: BMC Cardiovasc Disord. 2024 Oct 26;24(1):596. doi: 10.1186/s12872-024-04285-0
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
